Polylactic Acid/Polybutylene Adipate Terephthalate-Carbon Nanotube Nanobiocomposites with a Segregated Toughening Morphology Yielding Large Ductility for Biocompatible Materials by Utsab Ayan (18552401)

Subjects:

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Linear regressions of consumer stable carbon and nitrogen isotope values and collection date. by Nathan D. McTigue (10706460)

Subjects:

Mathematical treatments applied to data to correct stable isotope values for lipid content. by Nathan D. McTigue (10706460)

Subjects:

The number of expected vaccinations decreases with the expected vaccination time, whereas the peak of infections increases. by Simon K. Schnyder (16632244)

VACV sA28 and sH2 <i>in vitro</i> protein binding analyses. by Chi-Fei Kao (11414234)

“…The red dashed line in C marked the value of 0.06 ppm. The black dashed line in D marked 40% intensity decrease. …”

Costs and Benefits of Popular <i>P</i>‑Value Correction Methods in Three Models of Quantitative Omic Experiments by Steven R. Shuken (14500192)

“…The tremendous false discovery rate (FDR) benefit of correction was confirmed in a range of different contexts. No correction method can guarantee a low FDP in a single experiment, but the probability of a high FDP is small when a high number and proportion of corrected <i>p</i>-values are significant. …”

Proportion of genotype calls with both alleles correct (2), one allele incorrect (1) and two alleles incorrect (0) at different sequencing coverages. by Harrison J. Lamb (11722247)

Fig 7 - by Rajnish Prakash Singh (2847608)

Survival probability of cercariae in 0.38 ppt, 1.9 ppt, 3.8 ppt, and 5.7 ppt salinity treatments over a 24-hour period. by Ao Yu (1348512)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Fig 7 - by Yequan Chen (4743963)

Species occurrence along the NO₃¯ gradient (sorted by decreasing 25th percentile values). by Willem Kaijser (12872371)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Fig 7 - by Jacob L. Sheffield (18522351)

Effect of advanced chelate technology-based trace minerals on bone morphology and mineral contents observed in broiler chickens challenged with heat stress. by Taher Mohammadizad (19786989)

Subjects:

The nsP4-Q192L and C483Y mutations decrease the 4′-FlU sensitivity of both replication and transcription. by Peiqi Yin (6533747)